NPR

New Type Of Drug To Prevent Migraines Heads To Market

An antibody-based drug reduces the frequency of migraine headaches, according to data reviewed by the Food and Drug Administration. The agency approved Aimovig, priced at about $6,900 a year.

The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines among people prone to these sometimes crippling headaches.

That's welcome news to some of the millions of Americans who suffer from these . Much more common in women than

You're reading a preview, sign up to read more.

More from NPR

NPR5 min readPolitics
Misery Grows At Syrian Camp Holding ISIS Family Members
In recent visits to the camp, NPR was told of babies dying of malnutrition, and found women collapsed by roadsides. "There's a lack of supplies and the numbers of patients are huge," a doctor says.
NPR5 min read
As Employment Rises, African American Transplants Ride Jobs Wave To The South
At a time of low unemployment for African Americans, educated, well-connected professionals are starting new lives in cities such as Charlotte, N.C.
NPR2 min read
American Man Achieves Dream By Reaching Mount Everest Summit, Then Dies
Donald Lynn Cash of Utah achieved his goal of climbing the highest peaks on all seven continents. A traffic jam on Mount Everest may have impeded efforts to carry him down the mountain before he died.